What it is & primary uses
A cannabinoid with prescription evidence for specific seizure disorders and much weaker evidence for general wellness products.
Main benefits
- Prescription cannabidiol is effective for specific seizure disorders under medical supervision.
- Consumer-product anxiety, pain and sleep claims are not supported by comparable evidence, and label accuracy varies.
Studied protocols
Research doses are grouped by outcome. They describe study designs—not a personal prescription.
25–300 mg/day in nonprescription research; no universal wellness dose
- Study duration
- Commonly 4–12 weeks; protocol and outcome vary
- Interpretation
- Consumer-product anxiety, pain and sleep claims are not supported by comparable evidence, and label accuracy varies.
Clinical or experimental context—professional guidance is especially appropriate.
04Food sources & equivalents＋
Can food provide a studied amount?
Cannabidiol (CBD) in this supplemental form does not have a reliable one-to-one food equivalent.
Dietary exposure; verify composition before comparing with a studied supplement dose
- How this was estimated
- Dose Radar compares the declared active ingredient with official composition data or the studied standardized extract—not with marketing names.
- Important limitation
- Natural content, preparation, bioavailability and formulation vary. This comparison does not prove equal physiological effect.
Food equivalents compare ingredient mass using published composition values. They do not prove equal absorption, formulation, physiological effect, safety or personal need.
Source: NCCIH cannabis and cannabinoids evidence summary ↗05How to take it for absorption & tolerance＋
With dietary fat
Fat and formulation can materially change exposure; a meal does not turn an unsupported claim into an effective one.
- Practical approach
- Study-specific; keep food context consistent. Keep the formulation and daily total consistent with the evidence context shown above.
- Watch for
- Many CYP-metabolized medicines
Meal guidance reflects human pharmacokinetic, clinical, official-label or evidence-review sources where available. A food pairing can change absorption or tolerability, but does not make a supplement necessary, effective or safe for every person.
Source: NCCIH cannabis and cannabinoids evidence summary ↗06Supplement interaction check＋
An unlisted pair means no established pair-specific interaction was identified in this review—not proof that every dose, product or person is safe.
This is not proof that every dose, product or user context is safe. Medication and condition checks still apply.
07Research notes＋
Limited evidence for the stated context. Consumer-product anxiety, pain and sleep claims are not supported by comparable evidence, and label accuracy varies.
The displayed amount comes from human research or an official evidence summary. It is not a personalized prescription, and formulation can change whether the comparison is valid.
08Scientific references＋
Peer-reviewed human research and formal evidence reviews. Open each source to inspect the complete paper record.
NCCIH cannabis and cannabinoids evidence summary
Dose context: 25–300 mg/day in nonprescription research; no universal wellness dose
Prescription cannabidiol is effective for specific seizure disorders under medical supervision. Consumer-product anxiety, pain and sleep claims are not supported by comparable evidence, and label accuracy varies.
Cannabidiol (CBD): live PubMed review search
Dose context: Ingredient-specific human literature; dose and formulation vary
This live index supports source verification. A new paper does not change the Dose Radar grade until its design, population and formulation are reviewed.
09Expert & media references＋
Podcast and practitioner statements are clearly separated from research. They may explain practice or emerging ideas, but do not prove efficacy.
Dose Radar will leave this lane empty rather than invent or infer a professional opinion.